Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection

Infection and Immunity

Volumn 64, Issue 2, 1996, Pages 489-494

  Jones, D H ^a   McBride, B W ^a   Thornton, C ^a   O'Hagan, D T ^b   Robinson, A ^a   Farrar, G H ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; PERTUSSIS VACCINE; POLYGLACTIN;

ANIMAL EXPERIMENT; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; FEMALE; FIMBRIA; GASTROINTESTINAL MUCOSA; IMMUNIZATION; IMMUNOGENICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VACCINE PRODUCTION;

EID: 0030052972     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.2.489-494.1996     Document Type: Article

References (55)

1. Bockman, D. E., and M. D. Cooper. 1973. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix and Peyer's patches. An electron microscope study. Am. J. Anat. 136:455-477.
2. Brownlie, R. M., H. N. Brahmbhatt, D. C. White, M. W. Fountain, M. Rohde. J. Wehland, and K. N. Timmis. 1993. Stimulation of secretory antibodies against Bordetella pertussis antigens in the lungs of mice after oral or intranasal administration of liposome-incorporated cell-surface antigens. Microb. Pathog. 14:149-160.
3. Cahill, E. S., D. T. O'Hagan, L. Illum, A. Barnard, K. H. G. Mills, and K. Redhead. 1995 Immune responses and protection against Bordetella pertussis infection after intranasal immunisation of mice with filamentous haemagglutinin in solution of incorporated in biodegradable microparticles. Vaccine 13:455-462.
4. Cahill, E. S., D. T. O'Hagan, L. Illum, and K. Redhead. 1993. Mice are protected against Bordetella pertussis infection by intra-nasal immunisation with filamentous haemagglutinin. FEMS Microbiol. Lett. 107:211-216
5. Challacombe, S. J. 1984. Salivary antibodies and systemic tolerance in mice after oral immunisation with bacterial antigens. Ann. N Y. Acad. Sci. 409: 177-193
6. Challacombe, S. J., D. Rahman, H. Jeffery, S. S. Davis, and D. T. O'Hagan. 1992. Enhanced secretory IgA and systemic IgG antibody responses after oral immunisation with biodegradable microparticles containing antigen. Immunology 76:164-168
7. Cleland, J. L., M. F. Powell, A. Lim, L. Barron, P. W. Berman, D. J. Eastman, J. H. Nunberg, T. Wrin, and J. C. Vennari. 1994 Development of a single-shot subunit vaccine for HIV-1. AIDS Res. Hum. Retroviruses 10: S21-S26
8. Curtiss, R., S. Kelly, and P. Gulig. 1989. Selective delivery of antigens by recombinant bacteria Curr. Top. Microbiol Immunol. 146:35-49.
9. de Vos, T., and T. A. Dick. 1991 A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J. Immunol. Methods 141:285-288.
10. Eldridge, J. H., R. M. Gilley, J. K. Staas, Z. Moldoveanu, J. A. Meulbroek, and T. R. Tice. 1989. Biodegradable microspheres: vaccine delivery system for oral immunisation. Curr. Top. Microbiol. Immunol. 146:59-66.
11. Eldridge, J. H., C. J. Hammond, J. A. Meulbroek, J. K. Staas, R. M. Gilley, and T. R. Tice. 1990. Controlled vaccine release in the gut-associated lymphoid tissues. 1. Orally administered biodegradable microspheres target the peyer's patches J. Controlled Release 11:205-214.
12. Eldridge, J. H., J. A. Meulbroek, J. K. Staas, T. R. Tice, and R. M. Gilley. 1989 Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv. Exp. Med. Biol. 251:191-202.
13. Eldridge, J. H., J. K. Staas, J. A. Meulbroek, J. R. McGhee, T. R. Tice, and R. M. Gilley. 1991. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 28:287-294.
14. Eldridge, J. H., J. K. Staas, J. A. Meulbroek, T. R. Tice, and R. M. Gilley. 1991. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal entcrotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun. 59:2978-2986
15. Elson, C. O., W. Ealding, and J. Lefkowitz. 1984. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Methods 67:101-108.
16. Esparza, I., and T. Kissel. 1992. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid Vaccine 10:714-720.
17. Holmgren, J., N. Lycke, and C. Czerkinsky. 1993. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems Vaccine 11: 1179-1184.
18. Holmgren, J., and A.-M. Svennerholm. 1990. Development of oral vaccines againsl cholera and enterotoxigenic Escherichia coli diarrhea Scand J. Infect. Dis. Suppl 76:47-53.
19. Hora, M. S., R. K. Rana, J. H. Nunberg, T. R. Tice, R. M. Gilley, and M. E. Hudson. 1990 Release of human serum albumin from poly(lactide-co-glycolide) microspheres Pharm. Res 7:1190-1194.
20. Jackson, S., J. Mestecky, N. K. Childers, and S. M. Michalek. 1990. Liposomes containing anti-idiotype antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Infect. Immun. 58:1932-1936.
21. Jani, P., G. W. Halbert, J. Langridge, and A. T. Florence. 1990. Nanoparticle uptake by the rat gastrointestinal mucosa. quantitation and particle size dependency. J. Pharm. Pharmacol. 42:821-826.
22. Jenkins, P. G., K. A. Howard, N. W. Blackhall, N. W. Thomas, S. S. Davis, and D. T. O'Hagan. The quantitation of the absorption of microparticles into the intestinal lymph of Wistar rats. Int J. Pharm., in press.
23. Jones, D. H., B. W. McBride, H. Jeffery, D. T. O'Hagan, A. Robinson, and G. H. Farrar. 1995. Protection of mice from Boidetella pertussis respiratory infection using microencapsulated pertussis fimbriae. Vaccine 13:675-681.
24. Malay, K. J., A. M. Donachie, D. T. O'Hagan, and A. M. Mowat. 1994 Induction of mucosal and systemic immune responses by immunisation with ovalliumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology 81:661-667.
25. Marx, P. A., R. W. Compans, A. Gettie, J. K. Staas, R. M. Gilley, M. J. Mulligan, G. V. Yamshchikov, D. Chen, and J. H. Eldridge. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327
26. 25a. Matheson, M. 1996. Ph.D. thesis. Open University, Milton Keynes, United Kingdom.
27. McQueen, C. E., E. C. Boedeker, R. Reid, D. Jarboe, M. Wolf, M. Le, and W. R. Brown. 1993. Pili in microspheres protect rabbits from diarrhoea induced by E. coli strain RDEC-1. Vaccine 11:201-206
28. Menge, A. C., S. M. Michalek, M. W. Russell, and J. Mestecky. 1993 Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect Immun. 61:2162-2171.
29. Mestecky, J. 1987 The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin Immunol. 7:265-276.
30. Mestecky, J., Z. Moldoveanu, M. Novak, W.-Q. Huang, R. M. Gilley, J. K. Staas, D. Schafer, and R. W. Compans. 1994 Biodegradable microspheres for the delivery of oral vaccines. J. Controlled Release 28:131-141.
31. Modlin, J. F. 1991. Mucosal immunity following oral potiovirus vaccine and enhanced potency of inactivated poliovirus vaccine immunisation Pediatr. Infect. Dis. J. 10:976-978
32. Moldoveanu, Z., M. Novak, W.-Q. Huang, R. M. Gilley, J. K. Staas, D. Schafer, R. W. Compans, and J. Mestecky. 1993. Oral immunisation with influenza virus in biodegradable microspheres. J. Infect. Dis 167:84-90.
33. Moldoveanu, Z., J. K. Staas, R. M. Gilley, R. Ray, R. W. Compans, J. H. Eldridge, T. R. Tice, and J. Mestecky. 1989 Immune responses to influenza virus in orally and systemically immunised mice. Curr. Top. Microbiol. Immunol. 146:91-99.
34. Neutra, M. R., T. Phillips, E. Mayer, and D. J. Fishkind. 1987. Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch. Cell Tissue Res. 247:537-546.
35. O'Hagan, D., K. Palin, and S. S. Davis. 1989 Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunisation Vaccine 7:213-216
36. O'Hagan, D. T. 1990 Intestinal translocation of particulates - implications for drug and antigen delivery Adv. Drug Delivery Rev 5:265-285.
37. O'Hagan, D. T. 1994. Oral immunisation and the common mucosal immune system. p. 1-23 In D. T. O'Hagan (ed.). Novel delivery systems for oral vaccines CRC Press Inc., Boca Raton. Fla.
38. O'Hagan, D. T., H. Jeffery, M. J. J. Roberts, J. P. McGec, and S. S. Davis. 1991 Controlled release microparticles for vaccine development. Vaccine 9: 768-771.
39. O'Hagan, D. T., J. P. McGee, J. Holmgren, A. M. Mowat, A. M. Donachie, K. H. G. Mills, W. Gaisford, D. Rahman, and S. J. Challacombe. 1993. Biodegradable microparticles for oral immunisation. Vaccine 11:149-154.
40. O'Hagan, D. T., D. Rahman, J. P. McGee, H. Jeffery, M. C. Davies, P. Williams, and S. S. Davis. 1991. Biodegradable microparticles as controlled release antigen delivery systems Immunology 73:239-242.
41. Owen, R. L., and T. H. Ermak. 1990. Structural specialisations for antigen uptake and processing in the digestive tract. Springer Semin. Immunopathol. 12:139-152.
42. Pappo, J., and T. H. Ermak. 1989. Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. Clin. Exp. Immunol. 76:144-148.
43. Ray, R., M. Novak, J. D. Duncan, Y. Matsuoka, and R. W. Compans. 1993. Microencapsulated human parainfluenza virus induces a protective immune response. J. Infect. Dis. 167:752-755.
44. Roberts, M., I. Cropley, S. Chatfield, and G. Dougan. 1993. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunisation with P.69 and FHA. Vaccine 11:866-872.
45. Robinson, A., A. R. Gorringe, S. G. P. Funnell, and M. Fernandez. 1989. Serospecific protection of mice against intranasal infection with Bordetella pertussis Vaccine 7:321-324
46. Russell, M. W., and J. Mestecky. 1988. Induction of the mucosal immune response. Rev Infect Dis. 10:S440-S446.
47. Shahin, R., M. Leef, J. Eldridge, M. Hudson, and R. Gilley. 1995. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres Infect. Immun. 63: 1195-1200
48. Shahin, R. D., D. F. Amsbaugh, and M. F. Leef. 1992. Mucosal immunization with filamentous hemagghitinin protects against Bordetella pertussis respiratory infection Infect. Immun. 60:1482-1488.
49. Shalaby, W. S. W. 1995. Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies Clin. Immunol. Immunopathol 74:127-134.
50. Sneller, M. C., and W. Strober. 1986. M cells and host defense. J. Infect. Dis. 154:737-741.
51. Tacket, C. O., R. H. Reid, E. C. Hoedeker, G. Losonsky, J. P. Nataro, H. Bhagat, and R. Edelman. 1994 Enteral immunisation and challenge of volunteers given enterotoxigenic E coli CFA/H encapsulated in biodegradable microspheres. Vaccine 12:1270-1274.
52. Uchida, T., S. Martin, T. P. Foster, R. C. Wardley, and S. Grimm. 1994. Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin. Pharm. Res. 11:1009-1015.
53. Visscher, G. E., R. L. Robinson, H. V. Maulding, J. W. Fong, J. E. Pearson, and G. J. Argentieri. 1985. Biodegradation and tissue reaction to 50-50 poly(D-lactide-co-glycolide) microcapsules. J. Biomed. Mater. Res 19:349-365.
54. Walker, R. I. 1994 New strategies for using mucosal vaccination to achieve more effective immunisation. Vaccine 12:387-400.
55. Walker, R. T., and J. D. Clements. 1993. Use of heat-labile toxin of enterotoxigenic Escherichia coli to facilitate mucosal immunisation. Vaccine Res 2: 1-10.